Compass Therapeutics Inc. (CMPX)

2.88

-0.04 (-1.37%)

At close: Feb 28, 2025, 3:59 PM

2.85

-1.21%

After-hours: Feb 28, 2025, 05:45 PM EST

Compass Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-42.49M	-39.23M	-82.18M	-29.5M	-34.74M	-38.29M
Depreciation & Amortization	1.89M	1.9M	1.62M	2.4M	2.12M	1.92M
Stock-Based Compensation	6.12M	5.33M	4.03M	4.02M	915K	656K
Other Working Capital	-3.62M	-3.78M	6.44M	-4.03M	844K	1.18M
Other Non-Cash Items	5.97M	-871K	41K	-960K	116K	121K
Deferred Income Tax	n/a	n/a	50.58M	837K	109K	-261K
Change in Working Capital	-2.91M	-1.26M	6.25M	-3.6M	-257K	2.17M
Operating Cash Flow	-40.62M	-34.13M	-19.67M	-26.8M	-31.74M	-33.68M
Capital Expenditures	-30K	-212K	-1.57M	-106K	-466K	-2.02M
Acquisitions	n/a	176K	116K	144K	n/a	n/a
Purchase of Investments	-155.42M	-200.12M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	182.41M	48.95M	n/a	n/a	n/a	n/a
Other Investing Acitivies	27K	-150.99K	-318K	144.00	n/a	n/a
Investing Cash Flow	26.96M	-151.2M	-1.77M	38K	-466K	-2.02M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-159	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-159K	-480K	-281K	-6.32M	37.63K	64.03M
Financial Cash Flow	2.94M	75.76M	118.61M	48.54M	37.63K	64.03M
Net Cash Flow	-10.72M	-109.57M	97.17M	21.77M	-32.21M	28.33M
Free Cash Flow	-40.65M	-34.34M	-21.23M	-26.91M	-32.21M	-35.7M